AdaptHealth Corp. (NASDAQ:AHCO) Stock Has Consensus Price Target of $10.14

AdaptHealth Corp. (NASDAQ:AHCO) has earned a consensus recommendation of “Moderate Buy” from the nine brokerages that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and seven have given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $9.43.

A number of analysts have weighed in on the stock. Leerink Partners increased their target price on shares of AdaptHealth from $7.00 to $8.00 and gave the stock an “outperform” rating in a report on Thursday. Wall Street Zen raised AdaptHealth from a “sell” rating to a “hold” rating in a research report on Saturday. Robert W. Baird reduced their price target on AdaptHealth from $10.00 to $9.00 and set an “outperform” rating on the stock in a report on Thursday, September 17th. Jefferies Financial Group upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating and boosted their price target for the stock from $11.00 to $13.00 in a research note on Tuesday, July 21st. Finally, Truist Financial decreased their target price on AdaptHealth from $14.00 to $9.00 and set a “buy” rating for the company in a report on Wednesday, August 5th.

AdaptHealth Stock Performance

AdaptHealth stock opened at $7.33 on Monday. AdaptHealth has a 1 year low of $5.21 and a 1 year high of $13.43. The company has a market capitalization of $999.37 million, a P/E ratio of -2.44 and a beta of 1.36. The business has a 50 day moving average of $6.00 and a 200-day moving average of $9.07. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.12 and a quick ratio of 0.98.

AdaptHealth (NASDAQ:AHCO) last released its earnings results on Tuesday, November 3rd. The company reported ($1.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($1.08). AdaptHealth had a negative net margin of 7.07% and a positive return on equity of 3.36%. The business had revenue of $745.65 million for the quarter, compared to analysts’ expectations of $725.87 million. During the same quarter in the previous year, the business posted $0.16 earnings per share. AdaptHealth’s revenue for the quarter was down 9.1% on a year-over-year basis.

Hedge Funds Weigh In On AdaptHealth

Several institutional investors have recently bought and sold shares of the business. Dimensional Fund Advisors LP raised its position in AdaptHealth by 8.1% during the first quarter. Dimensional Fund Advisors LP now owns 6,920,973 shares of the company’s stock valued at $82,353,000 after purchasing an additional 518,274 shares in the last quarter. Principal Financial Group Inc. boosted its position in AdaptHealth by 25.1% during the first quarter. Principal Financial Group Inc. now owns 2,784,316 shares of the company’s stock valued at $33,133,000 after purchasing an additional 558,357 shares in the last quarter. Lazard Asset Management LLC raised its position in shares of AdaptHealth by 35.0% during the 1st quarter. Lazard Asset Management LLC now owns 1,669,454 shares of the company’s stock worth $19,867,000 after purchasing an additional 432,664 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of AdaptHealth by 87.7% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 847,085 shares of the company’s stock valued at $10,080,000 after buying an additional 395,668 shares during the period. Finally, Empowered Funds LLC boosted its position in shares of AdaptHealth by 1.4% during the 1st quarter. Empowered Funds LLC now owns 622,904 shares of the company’s stock worth $7,413,000 after purchasing an additional 8,602 shares in the last quarter. Institutional investors own 82.67% of the company’s stock.

AdaptHealth Company Profile

AdaptHealth Corp. (NASDAQ: AHCO) is a provider of home medical equipment, supplies and related healthcare services in the United States. The company helps patients manage chronic conditions and recover from illness or injury outside of traditional healthcare facilities, working with individuals, caregivers, physicians and payers.

Its products and services include respiratory equipment and supplies, oxygen therapy, sleep therapy devices such as continuous positive airway pressure systems, diabetes management products, mobility and accessibility equipment, and other durable medical equipment.